XML 20 R9.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 4 - Stockholders' Deficit
6 Months Ended
Dec. 31, 2017
Notes to Financial Statements  
Stockholders' Equity Note Disclosure [Text Block]
NOTE
4
-
STOCKHOLDERS’ DEFICIT
 
Common stock
 
During the
six
months ended
December 31, 2017,
the Company completed the following common share transactions:
 
 
(i)
On
July 13, 2017,
the Company issued
1,000,000
common shares as retainer fees pursuant to ongoing professional services agreement. The shares were measured at the grant date fair value of
$30,000
and recognized within selling, general and administrative expense.
 
 
(ii)
On
September 29, 2017,
the Company issued
600,000
shares pursuant to employee compensation agreements. The fair value of shares was recognized within share capital on the vesting date during the year ended
June 30, 2017.
 
During the
six
months ended
December 31, 2017,
the Company issued shares of common stock pursuant to debt agreements:
 
 
(i)
During the
six
months ended
December 31, 2017,
the Company issued
20,400,249
shares to settle
$732,726
in convertible debt (note
9
), net of gains on extinguishment of convertible debt of
$145,540.
 
 
(iii)
On
July 20, 2017,
the Company issued
925,000
shares to settle
$16,800
in debt. The shares were measured at the issue date fair value of
$27,750
with a gain on extinguishment of
$10,950
recognized within selling, general and administrative expense.
 
Preferred stock
 
As of
December 31, 2017
and
June 30, 2017,
there are
no
outstanding preferred shares.
 
Stock options
and restricted shares
 
The Company is reviewing several alternatives to replace its
2001,
2003,
and
2009
Stock Option Plans with a new omnibus stock option plan (the “New Plan”).   In certain cases, the Company has made contractual commitments to provide shares or stock option grants in anticipation of putting in place the New Plan.  The Company intends on obtaining the necessary approvals based on the attributes of the plan, and anticipates that this New Plan will be implemented prior to
June 30, 2019.
 
In
January 2001,
the Company adopted the Integral Technologies, Inc.
2001
Stock Plan (the
"2001
Plan"), a non-qualified stock option plan under which the Company
may
issue up to
2,500,000
stock options and bonuses of common stock of the Company to provide incentives to officers, directors, key employees and other persons who contribute to the success of the Company. This plan was amended during
December 2001
to increase the number of common stock options that
may
be granted from
2,500,000
to
3,500,000
stock options. As of
December 31, 2017,
there were
nil
(
June 30, 2017 -
nil
) common stock options available under this plan.
 
In
April 2003,
the Company adopted the Integral Technologies, Inc.
2003
Stock Plan (the
"2003
Plan"), a non-qualified stock option plan under which the Company
may
issue up to
1,500,000
stock options. As of
December 31, 2017,
there were
nil
(
June 30, 2017 -
nil
) common stock options available under this plan.
 
During the fiscal year ended
June 30, 2010,
the Company adopted the Integral Technologies, Inc.
2009
Stock Plan (the
"2009
Plan"), a non-qualified stock option plan under which the Company
may
issue up to
4,000,000
common stock options. As of
December 31, 2017,
there were
nil
(
June 30, 2016 -
nil
) common stock options available under this plan.
 
Stock option activity
 
The following summarizes the options outstanding and exercisable:
 
         
Number of Options
 
Expiry Date
 
Exercise Price
   
December 31, 2017
   
June 30, 2017
 
January 13, 2019
 
$0.25
   
50,000
   
50,000
 
January 13, 2020
 
$0.25
   
50,000
   
50,000
 
January 13, 2021
 
$0.25
   
50,000
   
50,000
 
Total outstanding
 
 
   
150,000
   
150,000
 
Total exercisable
 
 
   
150,000
   
150,000
 
 
The aggregate intrinsic value of options outstanding and exercisable as of
December 31, 2017
was
$nil
(
June 30, 2017 -
$nil
), respectively. The aggregate intrinsic values exclude options having a negative aggregate intrinsic value due to awards with exercise prices greater than market value. The intrinsic value is the difference between the market value of the shares and the exercise price of the award.
 
The weighted average remaining contractual lives for options outstanding and exercisable at
December 31, 2017
and
June 30, 2017
are
3.04
years and
3.54
years, respectively.
 
During
September 2017,
the Company entered into debt forgiveness agreements to settle
$561,737
in debt with related parties and consultants. In exchange the company agreed to issue
5,721,641
options at an exercise price of
$0.05
for periods expiring between
3
and
5
years and will vest when the Company increases its authorized shares issuable. The fair value of the options was measured at
$153,728
using the black-sholes option pricing model. The total amount of the debt less the fair value of the options has been recognized as a gain on settlement of liabilities.
 
Stock purchase warrants
 
The following summarizes information about the Company’s stock purchase warrants outstanding:
 
   
Number of
Warrants
   
Price Per Share
   
Weighted Average
Exercise Price
 
                           
Balance, June 30, 2017
   
4,044,465
   
$0.20
-
$0.30
     
$0.28
 
Granted
   
4,000,000
   
 
$0.05
 
     
$0.05
 
Expired
   
(4,044,465)
   
$0.20
-
$0.30
     
$0.28
 
                           
Balance, December 31, 2017
   
4,000,000
   
 
$0.05
 
     
$0.05
 
 
   
 
 
 
Number of Warrants
 
Expiry Date
 
Exercise Price
   
December 31, 2017
   
June 30, 2017
 
                   
October 1, 2017
 
$0.30
   
-
   
3,209,465
 
October 1, 2017
 
$0.20
   
-
   
835,000
 
November 16, 2022
 
$0.05
   
4,000,000
   
-
 
Total outstanding and exercisable
 
 
   
4,000,000
   
4,044,465
 
 
Share obligations
 
 
(a)
Pursuant to a separation agreement with the previous CFO, the Company will issue
36,000
shares of common stock with a fair value of
$3,600
and settle all unpaid fees from
July 1, 2016
to
February 10, 2017 (
effective date of resignation).
 
 
(b)
Pursuant to director’s agreements, the Company is obligated to issue
65,000
shares of common stock. As at
December 31, 2017,
these shares have
not
been issued and as such, the grant date fair value of
$37,650
has been recognized in obligation to issue shares within equity.